1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 3: Association between MRI measurements and adverse neurologic outcomes determined by univariate logistic regression analysis
Measurements Outcomes OR (95% CI) P Value TCD PDI <70 0.780 (0.662–0.919) .003 MDI <70 0.785 (0.665–0.927) .004 Major neurologic disability 0.815 (0.704–0.944) .006 Corpus callosal length MDI <70 0.876 (0.768–0.998) .047 High-risk or diagnosed CP 0.915 (0.838–0.999) .049
Note:—CP indicates cerebral palsy.